Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ARV-110
ARV-110
ASCO-GU – Arvinas sees the path to a prostate cancer niche
EP Vantage
Wed, 02/16/22 - 10:26 am
Arvinas
ARV-110
prostate cancer
ASCO-GU
ASCO: Arvinas unveils first-in-human data for novel protein degrader in prostate cancer
Fierce Biotech
Thu, 05/14/20 - 11:56 am
ASCO 2020
Arvinas
ARV-110
protein degradation
prostate cancer
2 Biotech Stocks That Soared Last Week
Motley Fool
Mon, 10/28/19 - 10:34 am
Biogen
Arvinas
aducanumab
protein degradation
ARV-110